- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLI[2,3-D]PYRIMIDIUM.](/upload/6698/4-1h-pyrazol-4-yl-7-2-trimethylsilyl-ethoxy-methyl-7h-pyrrolo-2-3-d-pyrimidine_530621.gif "4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLI[2,3-D]PYRIMIDIUM.")
4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLI[2,3-D]PYRIMIDIUM.
Product Name: 4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXYUS)METHYL) -7H-PYRROLO[2,3-D]PYRIMIDINUS
Formulae hypotheticae: C15H21N5OSi
Pondus hypotheticum: 315.45
CAS Registry Number: 941685-27-4
1-(1-ethoxyethyl) -4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Product Name:1-(1-ethoxyethyl) -4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Formulae hypotheticae: C13H23BN2O3
Molecular pondus:266.14
CAS Registry Number: 1029716-44-6
3-CYCLOPENTYLACRYLONITRILE
Product Name: 3-CYCLOPENTYLACRYLONITRILE
Formulae hypotheticae: C8H11N
Molecular pondus:12.18
CAS Registry Number: 591769-05-0
Cyclopentanecarbaldehyde
Product Name:Cyclopentanecarbaldehyde
Formulae hypotheticae: C6H10O
Molecular pondus: 98.14
CAS Subcriptio Number: 872-53-7
![1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione](/upload/6698/1-2-chloro-1-hydroxy-3-6-quinolinyl-propyl-2-5-pyrrolidinedione_873664.gif "1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione")
1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione
Product Name:1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione
Formulae hypotheticae: C16H15ClN2O3
Pondus hypotheticum: 318.75
CAS Registry Number: 1197377-31-3
4-(3-AMINO-1,2,4-TRIAZIN-6-YL)-2-FLUOROBENZONITRILE
Product Name:4-(3-AMINO-1,2,4-TRIAZIN-6-YL)-2-FLUOROBENZONITRILE
Formulae hypotheticae: C10H6FN5
Molecular pondus:215.19
CAS Registry Number: 1197377-47-1
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
